FAST NEWS: CanSino’s Covid Vaccine Approved for Boosters in China
The latest: CanSino Biologics Inc. (6185.HK) announced on Sunday that its recombinant novel coronavirus vaccine Convidecia has been approved for use in China in a “mixed” booster vaccination program to…
RELATED ARTICLES
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK -
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
